Riskpilot← Back to searchSign inGet full accessVETCUR BIOTEC ApS
APSActiveCVR 27984274Feldumvej 35Manufacture of prepared pet foods · NACE 1092Est. 20046 employees
Revenue 2025
DKK 2,1M
+24% vs 2024
EBITDA margin
27.5%
+185% vs 2024
Equity ratio
76.4%
Financial strength
Net profit 2025
DKK 417K
+297% vs 2024
| Revenue | DKK 2,1M | +24% |
| EBITDA | DKK 566K | +185% |
| Net profit | DKK 417K | +297% |
| Total assets | DKK 2,4M | +15% |
| Equity | DKK 1,9M | +29% |
| Employees | 6 | — |
Legal name
VETCUR BIOTEC ApS
CVR number
27984274
Legal form
Anpartsselskab
NACE code
1092 · Manufacture of prepared pet foods
Founded
8. august 2004
Share capital
DKK 125.000
Employees
6 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-06-30
Financial year
January – December
Signatory rights
Selskabet tegnes af én direktør
Company purpose
Selskabets formål er udvikling, produktion og salg af tilskudsfoder, plejeprodukter og foder til dyr. VET Centrets formål er at uddanne Veterinære ErnæringsTerapeuter, afholde kurser, workshops og foredrag relateret til virksomhedens kernekompetence - ernæring af dyr i bredeste forstand. Layout 4U har til formål at fremstille salgsfremmede materiale, brochurer, bannerreklamer, tryk mv. såvel til eget behov som i lønarbejde for trediepart.
Address
Feldumvej 35
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 2.267 | 1.853 | 1.526 | 1.666 | 2.060 |
| Staff expenses | -1.870 | -1.876 | -1.544 | -1.467 | -1.494 |
| EBITDA | 397 | -23 | -18 | 199 | 566 |
| Depreciation & amort. | -31 | -52 | -54 | -54 | -41 |
| EBIT | 366 | -75 | -72 | 145 | 525 |
| Net financials | -3 | -7 | -3 | -1 | 9 |
| Profit before tax | 363 | -82 | -75 | 143 | 534 |
| Tax | 78 | -0 | -25 | 39 | 118 |
| Net profit | 285 | -82 | -50 | 105 | 417 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 2.855 | 2.585 | 2.525 | 2.121 | 2.442 |
| Equity | 1.975 | 1.893 | 1.843 | 1.448 | 1.865 |
| Long-term debt | 0 | 0 | 102 | 90 | 90 |
| Short-term debt | 880 | 692 | 580 | 570 | 474 |
| Total debt | 880 | 692 | 682 | 659 | 564 |
EBITDA margin
27.5%
This company
15.8%
Market median
+74% vs market
20212025
Equity ratio
76.4%
This company
38.2%
Market median
+100% vs market
20212025
Return on equity
22.3%
This company
18.4%
Market median
+21% vs market
20212025
Net profit margin
20.2%
This company
8.1%
Market median
+149% vs market
20212025
Asset turnover
0.84×
This company
1.12×
Market median
+25% vs market
20212025
Debt / equity
0.31×
This company
0.62×
Market median
+50% vs market
20212025
- Annual report 2025Filed via CVR / Virk · Period 2024-07-01 – 2025-06-30
- Annual report 2024Filed via CVR / Virk · Period 2023-07-01 – 2024-06-30
- Annual report 2023Filed via CVR / Virk · Period 2022-07-01 – 2023-06-30
- Annual report 2022Filed via CVR / Virk · Period 2021-07-01 – 2022-06-30
- Annual report 2021Filed via CVR / Virk · Period 2020-07-01 – 2021-06-30
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
RM Chief Executive Officer | Chief Executive Officer | 2004 |
AL Founder | Founder | 2004 |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2008 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
CUR HOLDING OG INVEST ApS
VETCUR BIOTEC ApS Board members of VETCUR BIOTEC ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Rebekka Marianna Erika Gadeberg | Chief Executive Officer | 0 companies |
| Arvin Larsen | Founder | 0 companies |